Smarter Clinical Trial Design and Implementation at Lightning Speed
PhaseV Trial Optimizer uses AI/ML to simulate millions of adaptive, Bayesian, and fixed designs—cutting sample sizes, preserving power, and reducing costs across Phase 1–3 studies.
No obligations. Just insights.
Key Features
Transform Your Trial Designs with AI-Powered Optimization
PhaseV Trial Optimizer leverages AI/ML to optimize adaptive, Bayesian, and fixed trial designs & allows sponsors/CROs to implement the optimized designs in their studies
Run millions of trial simulations within minutes
Reduce trial sample size while preserving Type I error and power constraints, potentially yielding significant cost savings
Perform optimization & sample size re-estimation across a broad range of Phase 1-2 and 2-3 designs, including BOIN12, Seamless 2/3, Response-Adaptive Randomization, among others
Accelerated Insights
Optimizer Snapshot
Enables real-time multi-stakeholder decision-making by allowing users to:
- Simulate the impact of millions of adaptive and Bayesian design features within a click of a button
- Intervene early with confidence and adapt during the course of a trial.
- Reduce trial costs and duration while increasing success rate.
Key Results
Driving Smarter Trials with Clearer Outcomes
PhaseV adaptive designs have yielded:
- 10-40% reduction in sample size
- Similar reductions in trial costs and duration without compromising power
Casual to Adaptive
Bridging The Gap
For the first time, clinical teams can leverage causal ML-driven insights from previous trials and RWD to inform the design of future trials - all within a single, end-to-end multi-modal platform.
Key Benefits
Real-Time Evaluation of Trial Parameters to Maximize Success
This approach enables real-time evaluation of various parameters and their impact in order to increase the probability of success
Transforming Data into Actionable Insights
By turning data analysis into actionable insights, PhaseV Platform is helping biotech and pharma companies reduce failure rates, optimize trial investments and improve patient outcomes
“This integrated offering is unlike other solutions out there and far superior to those of the legacy players.”
